NRG-GU001
Terminated
Protocol Information
Tab containing protocol details, study design, and eligibility criteria
Tab containing study documents, informed consent forms, and study materials
Tab containing information for potential study participants
Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy for pT3/pT4 Urothelial Bladder Cancer
Principal Investigator
Libni Eapen
Status
Terminated
Open to Accrual
February 18, 2015
Open to Accrual
February 23, 2015
Closed to Accrual
February 1, 2017
Terminated
February 1, 2017
Disease Site
Genitourinary [GU] Bladder
Phase
II
Developmental Therapeutics
No
Primary Objective
To evaluate the ability of post-cystectomy adjuvant radiotherapy to safely reduce pelvic tumor recurrence, defined as pelvic recurrence-free survival.
Patient Population
Patients with pT3/pT4 pN0-2 urothelial (either pure urothelial or primary urothelial mixed with other subtypes) bladder cancer following radical cystectomy.
Target Accrual
185
Protocol Documents
Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website.
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.
-
Share this study.
-
-
-
-
